Nuvama lists out 4 reasons why they have rated MphasiS Buy. However they have a revised the price target lower. Find out why?

Investor concerns over the renewable energy sector's near-term prospects were evident on Friday, with Adani Green Energy ...

Nuvama Wealth Management announced the date to declare its third-quarter FY2024-25 results on Friday, January 24. Shares were ...

The brokerage firm, Nuvama, has raised its target price for UltraTech Cement to Rs 11,574 per share while maintaining its ...

NCW, a JV between Nuvama Asset Management and Cushman & Wakefield, has raised Rs 1,700 crore for its Prime Offices Fund to ...

The fund focuses on Grade A+ office spaces across key micro-markets in India's six largest cities: Bengaluru, the National ...

Nuvama and Cushman & Wakefield Management Pvt Ltd (NCW) has raised Rs 1,700 crore under its new real estate fund for making ...

Nuvama-Cushman & Wakefield JV raises ₹1,700 crore for Prime Offices Fund targeting India's commercial real estate sector.

(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine months, after missing its third-quarter profit estimates on lower sales and ...

India's Orient Cement reported a slump in third-quarter profit on Friday due to weak prices of the key construction material amid seasonally low demand.

Analysts at Nuvama believe that BSE has room to grow its derivative active customer base. They also estimate that the ...

Shares of Pidilite Industries Ltd surged as much as 9 per cent during the trading session on Thursday, following the ...